Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ocular Therapeutix

11.33
-0.0500-0.44%
Post-market: 11.330.00000.00%17:20 EDT
Volume:2.13M
Turnover:24.16M
Market Cap:1.80B
PE:-9.85
High:11.57
Open:11.56
Low:11.23
Close:11.38
Loading ...
Jul 01, 2020

Major Issues Report

8-K - Current report
Jun 09, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
May 22, 2020

Major Issues Report

8-K - Current report
May 21, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 14, 2020

Major Issues Report

8-K - Current report
May 08, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 08, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Apr 28, 2020

Major Issues Report

8-K - Current report
Apr 13, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Mar 25, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Mar 12, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 12, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 12, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Mar 03, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Feb 05, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 10, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Nov 12, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]